Organon & CO DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
OGN
Organon & CODEFA14A: Organon & Co. Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Shareholder Vote
Organon & Co. has scheduled its annual shareholder meeting for June 10, 2025, outlining proposals including the election of directors, executive compensation, and an amendment to the incentive stock plan.
NYSE
OGN
Organon & COOrganon & Co. invites shareholders to its 2025 Annual Meeting, showcasing strong 2024 business results with revenue growth across all franchises and strategic investments for future growth.
NYSE
OGN
Organon & COOrganon & Co. announces its 2024 Annual Meeting of Shareholders to be held on June 4, 2024, outlining key proposals for voting.
NYSE
OGN
Organon & COOrganon's 2024 proxy statement outlines the company's strategic focus on profitable growth, women's health, and shareholder value, inviting shareholders to the annual meeting on June 4, 2024.